2013
DOI: 10.1038/nrurol.2013.110
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia, notch signalling, and prostate cancer

Abstract: The notch signalling pathway is involved in differentiation, proliferation, angiogenesis, vascular remodelling, and apoptosis. Deregulated expression of notch receptors, ligands, and targets is observed in many solid tumours, including prostate cancer. Hypoxia is a common feature of prostate tumours, leading to increased gene instability, reduced treatment response, and increased tumour aggressiveness. The notch signalling pathway is known to regulate vascular cell fate and is responsive to hypoxia-inducible f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
52
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 80 publications
(53 citation statements)
references
References 132 publications
1
52
0
Order By: Relevance
“…Tumor hypoxia is a pathological hallmark that may be correlated with metabolism, the activation of cell signaling, angiogenesis, differentiation, necrosis or cell apoptosis, tumor development and aggressiveness, etc [10][11][12].. Additionally, tumor hypoxia can have an adverse impact on the prognosis of some cancers (i.e., invasive breast cancer or cervical cancer) and the efficacy of chemo-and radiotherapy [13,14]. Hypoxia-inducible factor-2α (HIF-2α), also named the endothelial PAS domain protein 1 (EPAS1), a member of the hypoxia-inducible factors (HIFs), is an essential marker, which mediates the transcriptional response to hypoxia stress [15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…Tumor hypoxia is a pathological hallmark that may be correlated with metabolism, the activation of cell signaling, angiogenesis, differentiation, necrosis or cell apoptosis, tumor development and aggressiveness, etc [10][11][12].. Additionally, tumor hypoxia can have an adverse impact on the prognosis of some cancers (i.e., invasive breast cancer or cervical cancer) and the efficacy of chemo-and radiotherapy [13,14]. Hypoxia-inducible factor-2α (HIF-2α), also named the endothelial PAS domain protein 1 (EPAS1), a member of the hypoxia-inducible factors (HIFs), is an essential marker, which mediates the transcriptional response to hypoxia stress [15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…13,14 Thus, ICN forms a complex with CSL (CBF1/Su(H)/Lag-1) and triggers the transcription of its targets such as cyclin D, Hey family and Hes (hairy enhancer of split) family. 15 Deregulated Notch signaling has been observed in a variety of human cancers including prostate cancer. [16][17][18][19] For example, Jagged-1 expression is associated with prostate cancer metastasis and recurrence.…”
Section: Introductionmentioning
confidence: 99%
“…Many cell signaling pathways play different roles in the development and progression of prostate cancer, such as NF-kB, JAK/STAT, MAPK, Wnt, PI3K/Akt, and Notch signaling. Among these, the Notch signaling pathway, which is present in most multicellular organisms, plays a role in cancer metastasis by governing embryonic development, maintaining tumor stemness, modulating the epithelial-to-mesenchymal transition (EMT), and affecting tumor angiogenesis processes (12)(13)(14). Several studies have demonstrated that the Notch signaling pathway is required for prostatic growth and plays a key role in the progression and metastasis of prostate cancer (15)(16)(17).…”
Section: Introductionmentioning
confidence: 99%